Our board
Vision, values and strategy
Ian Hamilton - Chairman
Ian chairs the board and holds senior positions within the agricultural sector, including Chairman of Scottish life sciences business Horizon Proteins, global bovine technology company Vytelle and agrochemical supply business Zantra. He also is a Non-Executive Advisor to Wheatsheaf Investments and chairs his own private portfolio of companies. Ian holds a BSc (Hons) degree in Agriculture from the University of Edinburgh.
Fiona Marshall - CEO
Fiona has over 15 years working in the diagnostics sector for SME’s and international groups such as Alere, BBI Solutions and AgPlus Diagnostics. She has multidisciplinary skills from R&D through to commercialisation of diagnostic products in various fields such as Clinical, Veterinary and Defence. She has led many businesses from start-up to delivery and combines strong leadership and mentoring skills to support SMEs to grow and scale.
Ross McDermid - Director of Commercialisation
Ross brings over 25 years of sales and marketing experience to the team. Before joining Biotangents, he spent the last 13 years working for Covetrus (formerly Henry Schein Animal Health), latterly as European Marketing Director leading and managing 12 country teams to deliver commercial success.
Professor Richard Hammond - Non-Executive Director
Richard qualified as a veterinary surgeon in 1991 and brings experience across clinical, academic and commercial veterinary sectors. He was awarded a fellowship of the Royal College of Veterinary Surgeons in 2020 for meritorious contributions to the profession, a PhD in 1999 in biochemical pharmacology, and a master’s in medical education in 2012. He has worked commercially for a major pharmaceutical company, was part of the management team that set up the veterinary school at the University of Nottingham, and was CEO of Langford Vets.
Ole Kring - Non-Executive Director
Ole has extensive knowledge of the veterinary diagnostics sector and has developed and sold diagnostics for companion animals (pets) for more than 10 years. He is the former CEO and president of Zoetis Denmark, Zoetis being the number 1 global player in the agritech sector. As CEO of Scandinavian Micro Biodevices he achieved an €80m exit in the form of an acquisition by Zoetis, which mirrors our ambitions. Ole is a partner at VF Venture with responsibility for life science investments.
Professor Steve Howell - Investor Director
Steve is an experienced entrepreneur and founder of over a dozen Life Science companies including investment company Innova Partnerships and Unilever joint venture Penrhos Bio. He has been involved in the M&A activities of six companies, three on the buy side and three on the sell side. Steve is also Visiting Professor of Commercial Innovation at Kings College London.
David Glen - Corporate Advisor and Finance
David joined DC Consulting in 2008 having trained and qualified with an independent chartered accountancy firm in Broughty Ferry, Dundee. Now heading up DC’s Edinburgh office, David has a strong track record in supporting clients across a broad spectrum of assignments, including helping clients to become “investor ready” prior to guiding them through the raising of investment capital, incorporating equity, debt and grant funding. David brings this expertise to Biotangents, where he advises on corporate and financial strategy.